-The Telegraph The Supreme Court today agreed to take up "as early as possible" a plea challenging a recent NDA government decision that is alleged to have paved the way for a sharp rise in the prices of life-saving drugs. Petitioner Manohar Lal Sharma, a lawyer, has demanded a CBI probe into a September 22 government order that he says frees a list of medicines from pricing control. His public interest plea alleges...

-FirstPost.com With the hype of his Madison Square Garden show overshadowing everything else, Prime Minister Narendra Modi's US visit was dubbed as a great bilateral victory for India. As the popular consensus went, Modi wowed both the Indian Americans and American politicians and even managed to get a joint op-ed article with President Barack Obama in the Washington Post stressing the importance of the partnership between the two countries. Was it really...

-The Hindu Business Line   Anonymity can protect unpopular individuals from retaliation - and their ideas from suppression - at the hand of an intolerant society The Supreme Court of India has, thankfully, decided to reconsider an earlier order calling for revealing the identity of the whistle-blower while hearing a petition alleging gross misconduct against the Director of the country's foremost police agency, the Central Bureau of Investigation (CBI). On September 15, a...

-Down to Earth   Poverty line figures hide people's aspirations There are lies, damn lies and statistics, American author Mark Twain once wrote echoing a similar statement by the British statesman Benjamin Disraeli. Statistics aim to reveal a lot, but they conceal vital information. This concealing tendency of statistics explains much of the flak received by the Planning Commission when it released figures on the poverty line. In 2012, the commission announced that...

-The Hindu   No one can attack India's well-founded Intellectual Property regime as being weak merely because a drug that is claimed to be an invention fails the test of law India and its intellectual property (IP) laws have been the subject of sharp criticism recently. Now, there is talk of the government invoking emergency provisions with regard to Dasatinib, a cancer drug. The decibel level may go up several notches. Let us look...